TrialReader


SPI and Remifentanil in Skull Pin Fixation

NCT06331663 — Phase 4, Unknown, 27 participants, Kaohsiung Medical University Chung-Ho Memorial Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

To Explore the Optimal Dose of Remifentanil for Skull Pin Fixation Under Surgical Pleth Index Monitor in Intracranial Surgery

RegistryNCT06331663
StatusUnknown
PhasePhase 4
Study typeInterventional; na, single group, masking: none, prevention
Enrollment27 (Estimated)
SponsorKaohsiung Medical University Chung-Ho Memorial Hospital (Other)
ConditionsPain, Procedural
InterventionsRemifentanil (Drug)
Datesstart 2024-04-01 (estimated), primary completion 2024-06-20 (estimated), completion 2024-06-20 (estimated), first posted 2024-03-26, last updated 2024-03-26
Locations1 site in Taiwan

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Pain, Procedural All trials of Remifentanil

-Summary

Forty patients were enrolled, and all patients used total intravenous anesthesia (remifentanil-propofol based total intravenous analgesia) as anesthesia induction and maintenance. According to the preliminary data of this department, patients who underwent intracranial surgery for skull pin fixation used remifentanil 5.0-6.0 ng/ml, while the hemodynamics is relatively stable. Therefore, when this plan is implemented, the patient needs to be under the same depth of anesthesia (monitored by electroencephalography, maintaining a value of 40-60), first start with remifentanil 5.0 ng/ml, and use the up and down method as adjust 0.5 ng/ml of concentration of remifentanil each time. Inadequate antinociception (Surgical Pleth Index(SPI) > 80 and hyperdynamics (the increased heart rate (HR) and mean blood pressure (MBP) above 20% of baseline or HR>100bpm and arterial blood pressure(ABP)>180/100mmHg)) is defined as failure, therefore we increase remifentanil by 0.5 ng/ml; otherwise, the setting is considered successful without abovementioned situations.

Data collection: heart rate, mean blood pressure, Surgical Pleth Index, bispectral Index, pulse pressure variance, systolic pressure variance, concentrations of propofol and remifentanil before 2 mins, during, 5, and 15 mins of skull pin fixation were recorded and analyzed.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
ArmsExperimentalDrug: RemifentanilNeurosurgery with fixation
  • Remifentanil (Drug): first start with remifentanil 5.0 ng/ml, and use the up and down method as adjust 0.5 ng/ml of concentration of remifentanil each time. Inadequate antinociception (Surgical Pleth Index(SPI) > 80 and hyperdynamics (the increased heart rate (HR) and mean blood pressure (MBP) above 20% of baseline or HR>100bpm and arterial blood pressure(ABP)>180/100mmHg)) is defined as failure, therefore we increase remifentanil by 0.5 ng/ml; otherwise, the setting is considered successful without abovementioned situations.

+Outcome measures

Primary outcomes

  • 50% effect concentration of remifentanil [peri-fixation period]: 50% effect concentration of remifentanil will be recorded at 2 mins before fixation, during fixation, 5 mins after fixation, and 15 mins after fixation.
  • 90% effect concentration of remifentanil [peri-fixation period]: 90% effect concentration of remifentanil will be recorded at 2 mins before fixation, during fixation, 5 mins after fixation, and 15 mins after fixation.

+Eligibility

Sex: All, ages: 20 Years to 80 Years

Inclusion Criteria:

1. Must be at least 20 years old and less than 80 years old
2. With anesthesia risk grade below grade three (including grade three) (ASA I\~III).
3. Patients who are expected to undergo intracranial surgery for skull pin fixation

Exclusion Criteria:

1. Those with anesthesia risk classification ASA class IV or higher
2. Those who are allergic to opioid analgesics or propofol drugs
3. Emergency patients

+Locations (1)

FacilityCityCountryStatus
Kaohsiung Medical University Chung-Ho Memorial HospitalKaohsiung CityTaiwan

My Notes